These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23087052)

  • 1. Humoral immunity and the development of obliterative bronchiolitis after lung transplantation: is there a link?
    Emtiazjoo AM; Wilkes DS
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):145-9. PubMed ID: 23087052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of autoimmunity in obliterative bronchiolitis after lung transplantation.
    Weber DJ; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2013 Mar; 304(5):L307-11. PubMed ID: 23262227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17A Blockade Attenuates Obliterative Bronchiolitis and IFN-γ Cellular Immune Response in Lung Allografts.
    Gupta PK; Wagner SR; Wu Q; Shilling RA
    Am J Respir Cell Mol Biol; 2017 Jun; 56(6):708-715. PubMed ID: 28118023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 T Cells but Not Th17 Cells Are Required for Mouse Lung Transplant Obliterative Bronchiolitis.
    Wu Q; Gupta PK; Suzuki H; Wagner SR; Zhang C; W Cummings O; Fan L; Kaplan MH; Wilkes DS; Shilling RA
    Am J Transplant; 2015 Jul; 15(7):1793-1804. PubMed ID: 25773063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients.
    Botturi K; Lacoeuille Y; Thomas P; Boniface S; Reynaud-Gaubert M; Magnan A
    Eur Respir J; 2008 Jun; 31(6):1167-76. PubMed ID: 18256061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation.
    Kroshus TJ; Kshettry VR; Savik K; John R; Hertz MI; Bolman RM
    J Thorac Cardiovasc Surg; 1997 Aug; 114(2):195-202. PubMed ID: 9270635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.
    Todd JL; Palmer SM
    Chest; 2011 Aug; 140(2):502-508. PubMed ID: 21813529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of chronic lung allograft dysfunction: new insights from the bench and beyond.
    Shilling RA; Wilkes DS
    Am J Transplant; 2009 Aug; 9(8):1714-8. PubMed ID: 19519813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection.
    Sumpter TL; Wilkes DS
    Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1129-39. PubMed ID: 15136293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for indirect allorecognition in lung transplant recipients with obliterative bronchiolitis.
    Stanford RE; Ahmed S; Hodson M; Banner NR; Rose ML
    Am J Transplant; 2003 Jun; 3(6):736-42. PubMed ID: 12780566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchiolitis obliterans in lung transplantation: the good, the bad, and the future.
    Grossman EJ; Shilling RA
    Transl Res; 2009 Apr; 153(4):153-65. PubMed ID: 19304274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-transplant bronchiolitis obliterans.
    Boehler A; Estenne M
    Eur Respir J; 2003 Dec; 22(6):1007-18. PubMed ID: 14680094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics and bronchiolitis obliterans following lung transplantation.
    Crowley S; Egan JJ
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):923-30. PubMed ID: 16307505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung transplantation: infection, inflammation, and the microbiome.
    Nakajima T; Palchevsky V; Perkins DL; Belperio JA; Finn PW
    Semin Immunopathol; 2011 Mar; 33(2):135-56. PubMed ID: 21271250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute rejection and humoral sensitization in lung transplant recipients.
    Martinu T; Chen DF; Palmer SM
    Proc Am Thorac Soc; 2009 Jan; 6(1):54-65. PubMed ID: 19131531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human and murine obliterative bronchiolitis in transplant.
    McDyer JF
    Proc Am Thorac Soc; 2007 Jan; 4(1):37-43. PubMed ID: 17202290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of complement activation in obliterative bronchiolitis post-lung transplantation.
    Suzuki H; Lasbury ME; Fan L; Vittal R; Mickler EA; Benson HL; Shilling R; Wu Q; Weber DJ; Wagner SR; Lasaro M; Devore D; Wang Y; Sandusky GE; Lipking K; Pandya P; Reynolds J; Love R; Wozniak T; Gu H; Brown KM; Wilkes DS
    J Immunol; 2013 Oct; 191(8):4431-9. PubMed ID: 24043901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an antibody specific to major histocompatibility antigens detectable by flow cytometry after lung transplant is associated with bronchiolitis obliterans syndrome.
    Palmer SM; Davis RD; Hadjiliadis D; Hertz MI; Howell DN; Ward FE; Savik K; Reinsmoen NL
    Transplantation; 2002 Sep; 74(6):799-804. PubMed ID: 12364858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel charcoal-induced model of obliterative bronchiolitis-like lesions: implications of chronic nonspecific airway inflammation in the development of posttransplantation obliterative bronchiolitis.
    Lee AG; Wagner FM; Chen MF; Serrick C; Giaid A; Shennib H
    J Thorac Cardiovasc Surg; 1998 Apr; 115(4):822-7. PubMed ID: 9576217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.